CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 8.92
+0.04 (0.45%)
Aug 19, 2025, 11:45 AM HKT
CStone Pharmaceuticals Revenue
CStone Pharmaceuticals had revenue of 49.45M CNY in the half year ending June 30, 2025, a decrease of -81.09%. This brings the company's revenue in the last twelve months to 202.49M, down -55.65% year-over-year. In the year 2024, CStone Pharmaceuticals had annual revenue of 407.21M, down -12.21%.
Revenue (ttm)
202.49M CNY
Revenue Growth
-55.65%
P/S Ratio
58.62
Revenue / Employee
1.50M CNY
Employees
135
Market Cap
13.01B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 407.21M | -56.64M | -12.21% |
| Dec 31, 2023 | 463.84M | -17.52M | -3.64% |
| Dec 31, 2022 | 481.36M | 237.65M | 97.51% |
| Dec 31, 2021 | 243.72M | -795.11M | -76.54% |
| Dec 31, 2020 | 1.04B | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 35.81B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 71.34B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |